Literature DB >> 9707360

Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa.

W H Wernsdorfer1, B Landgraf, V A Kilimali, G Wernsdorfer.   

Abstract

Benflumetol, a novel antimalarial compound belonging to the fluorenes (2,3-benzindenes), has high blood schizontocidal activity, in vitro and in vivo, against mammalian plasmodia, including chloroquine-resistant Plasmodium falciparum. Due to its molecular structure benflumetol occurs in the dextrorotatory and the laevorotatory form. Normal synthesis yields the racemate of both enantiomers. Enantiomers of some antimalarial drugs possess different specific activity. It was therefore of interest to compare the response of P. falciparum to the enantiomers and the racemate of benflumetol in a variety of fresh, natural isolates. Measuring the concentration-specific inhibition of schizont maturation, the parallel investigation of 29 isolates produced no evidence of substantial activity differences between (+)-benflumetol, (-)-benflumetol and racemic benflumetol, the mean EC-50 values being 8.87, 9.71 and 12.44 nmol/l blood-medium-mixture, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707360     DOI: 10.1016/s0001-706x(97)00141-1

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  13 in total

1.  Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand.

Authors:  H Noedl; T Allmendinger; S Prajakwong; G Wernsdorfer; W H Wernsdorfer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

Authors:  N J White; M van Vugt; F Ezzet
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

3.  In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether.

Authors:  P Tanariya; P Tippawangkoso; J Karbwang; K Na-Bangchang; W H Wernsdorfer
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

4.  Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration.

Authors:  Paul Achile Akpa; Joseph Abuchi Ugwuoke; Anthony Amaechi Attama; Chinenye Nnenna Ugwu; Ezinwanne Nneoma Ezeibe; Mumuni Audu Momoh; Adaeze Chidiebere Echezona; Franklin Chimaobi Kenechukwu
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

5.  Synergistic interaction between monodesbutyl-benflumetol and retinol in Plasmodium falciparum.

Authors:  Maria Parizek; Jeeraphat Sirichaisinthop; Gunther Wernsdorfer; Harald Noedl; Herwig Kollaritsch; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies.

Authors:  Michael J Delves; Robert E Sinden
Journal:  Malar J       Date:  2010-01-29       Impact factor: 2.979

Review 7.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.

Authors:  B Pradines; A Tall; T Fusai; A Spiegel; R Hienne; C Rogier; J F Trape; J Le Bras; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

10.  Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda.

Authors:  Christof Prugger; Michael Engl; Martin Ogwang; Franz Ploner; Martin Ploner; Doris Gluderer; Gunther Wernsdorfer; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.